Related Experiment Videos
[Hydantoin fetal syndrome]
P M Dang1, B Dufetelle, J M Bonnetblanc
1Service de Dermatologie, CHRU Limoges.
Insights
Foetal hydantoin syndrome (FHS) can cause distal finger hypoplasia. Early detection via lymphocyte glucocorticoid receptors or amniocentesis, and prevention with folate, are key for managing FHS risks.
Area of Science:
- Teratology
- Developmental Biology
- Clinical Genetics
Background:
- Foetal hydantoin syndrome (FHS) is a spectrum of birth defects.
- It is associated with maternal anticonvulsant drug use during pregnancy.
- Potential mechanisms involve collagen, cytochrome P450, and arachidonic acid metabolism disruptions.
Observation:
- A case of distal finger hypoplasia was observed in an infant.
- This condition was associated with foetal hydantoin syndrome (FHS).
Findings:
- FHS occurrence may stem from metabolic pathway abnormalities.
- Risk assessment for FHS can involve measuring lymphocyte glucocorticoid receptors.
- Amniocentesis can assess epoxide hydrolase activity for FHS risk evaluation.
Implications:
- Early detection and risk assessment of FHS are possible through specific biomarkers.
- Folate supplementation during pregnancy may prevent FHS development.
- Understanding FHS pathogenesis aids in preventing birth defects associated with maternal drug exposure.
Abstract:
We report a case of distal finger hypoplasia associated with foetal hydantoin syndrome (FHS). The occurrence of this syndrome is thought to be due to abnormalities of collagen, cytochrome P 450 and arachidonic acid metabolism. The risk of developing FHS could be evaluated by counting the glucocorticoid receptors of lymphocytes or by measuring epoxide hydrolase activity through amniocentesis. FHS can be prevented by taking folates during pregnancy.